• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Avoidant/Restrictive Food Intake Disorder Symptoms Are Not as Frequent as Other Eating Disorder Symptoms When Ulcerative Colitis Is in Remission.溃疡性结肠炎缓解期时,回避/限制型食物摄入障碍症状不如其他饮食障碍症状常见。
J Crohns Colitis. 2024 Sep 3;18(9):1510-1513. doi: 10.1093/ecco-jcc/jjae052.
2
Assessing Avoidant/Restrictive Food Intake Disorder (ARFID) Symptoms Using the Nine Item ARFID Screen in >9000 Swedish Adults With and Without Eating Disorders.使用 9 项 ARFID 筛查在 >9000 名瑞典成人(有和无饮食障碍者)中评估回避/限制型食物摄入障碍(ARFID)症状。
Int J Eat Disord. 2024 Nov;57(11):2143-2155. doi: 10.1002/eat.24274. Epub 2024 Aug 8.
3
Validation of the nine item ARFID screen (NIAS) subscales for distinguishing ARFID presentations and screening for ARFID.验证九项进食障碍筛查量表(NIAS)分量表区分进食障碍表现和筛查进食障碍的能力。
Int J Eat Disord. 2021 Oct;54(10):1782-1792. doi: 10.1002/eat.23520. Epub 2021 Apr 22.
4
The Polish Version of the Avoidant/Restrictive Food Intake Disorder Questionnaire-Parents Report (ARFID-Q-PR) and the Nine Items Avoidant/Restrictive Food Intake Disorder Screen-Parents Report (NIAS-PR): Maternal Perspective.《回避/限制型食物摄入障碍问卷-父母报告版(ARFID-Q-PR)》和《回避/限制型食物摄入障碍 9 项筛查-父母报告版(NIAS-PR)》的波兰语版本:母亲视角。
Nutrients. 2022 Aug 2;14(15):3175. doi: 10.3390/nu14153175.
5
Validation of the youth-nine item avoidant/restrictive food intake disorder screen.青少年九项回避/限制型食物摄入障碍筛查量表的验证
Eur Eat Disord Rev. 2024 Jan;32(1):20-31. doi: 10.1002/erv.3017. Epub 2023 Aug 6.
6
Risk of avoidant/restrictive food intake disorder in patients with inflammatory bowel disease: predictive value of disease phenotype, disease activity and food literacy.炎症性肠病患者患回避/限制性食物摄入障碍的风险:疾病表型、疾病活动度和食物素养的预测价值
J Eat Disord. 2023 Nov 28;11(1):211. doi: 10.1186/s40337-023-00936-3.
7
Relationships among symptoms of gastroparesis to those of avoidant/restrictive food intake disorder in patients with gastroparesis.胃轻瘫患者的胃轻瘫症状与回避/限制型进食障碍症状之间的关系。
Neurogastroenterol Motil. 2024 Feb;36(2):e14725. doi: 10.1111/nmo.14725. Epub 2023 Dec 7.
8
Eating disorder symptoms, including avoidant/restrictive food intake disorder, in patients with disorders of gut-brain interaction.肠脑互动障碍患者的饮食失调症状,包括回避/限制型食物摄入障碍。
Neurogastroenterol Motil. 2022 Aug;34(8):e14258. doi: 10.1111/nmo.14258. Epub 2021 Oct 24.
9
Psychometric properties of the nine-item avoidant/restrictive food intake disorder screen (NIAS) in Turkish children.土耳其儿童中九项回避/限制性食物摄入障碍筛查量表(NIAS)的心理测量特性。
J Eat Disord. 2024 Feb 19;12(1):30. doi: 10.1186/s40337-024-00987-0.
10
Association between avoidant/restrictive food intake disorder risk, dietary attitudes and behaviors among Chinese patients with inflammatory bowel disease: a cross-sectional study.中国炎症性肠病患者回避/限制性食物摄入障碍风险与饮食态度及行为之间的关联:一项横断面研究
BMC Gastroenterol. 2025 Mar 6;25(1):144. doi: 10.1186/s12876-025-03727-z.

引用本文的文献

1
Co-occurring weight- and/or shape-motivated restriction in 5,747 adults with probable ARFID.5747名患有疑似回避性/restrictive食物摄入障碍(ARFID)的成年人中同时存在体重和/或体型相关的进食限制。
medRxiv. 2025 Jul 29:2025.07.28.25332146. doi: 10.1101/2025.07.28.25332146.
2
Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain.系统性硬化症成人患者的回避或限制性食物摄入障碍症状:西班牙的一项全国性研究
Arthritis Care Res (Hoboken). 2025 May 12. doi: 10.1002/acr.25569.
3
From Food Fears to Food Freedom: How Do We Best Manage Restrictive Eating in Inflammatory Bowel Disease?从食物恐惧到食物自由:我们如何最好地管理炎症性肠病中的限制性饮食?
Crohns Colitis 360. 2025 Apr 14;7(2):otaf019. doi: 10.1093/crocol/otaf019. eCollection 2025 Apr.
4
Systematic Review and Meta-Analysis: Examining the Psychometric Evaluations of Disordered Eating Scales in Adults Living With Gastrointestinal Conditions.系统评价与荟萃分析:审视胃肠道疾病成年患者饮食失调量表的心理测量学评估
Neurogastroenterol Motil. 2025 May;37(5):e15018. doi: 10.1111/nmo.15018. Epub 2025 Feb 10.

本文引用的文献

1
Psychological Considerations for Food Intolerances: Celiac Sprue, Eosinophilic Esophagitis, and Non-Celiac Gluten Sensitivity.食物不耐受的心理考虑因素:乳糜泻、嗜酸性食管炎和非乳糜泻麸质敏感性。
Gastroenterol Clin North Am. 2022 Dec;51(4):753-764. doi: 10.1016/j.gtc.2022.07.003. Epub 2022 Oct 22.
2
The factor structure and validity of a diagnostic interview for avoidant/restrictive food intake disorder in a sample of children, adolescents, and young adults.在儿童、青少年和年轻成年人样本中,用于诊断回避/限制型食物摄入障碍的诊断访谈的因子结构和有效性。
Int J Eat Disord. 2022 Nov;55(11):1575-1588. doi: 10.1002/eat.23792. Epub 2022 Aug 18.
3
British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease.英国营养协会关于炎症性肠病患者营养评估和饮食管理的共识指南。
J Hum Nutr Diet. 2023 Feb;36(1):336-377. doi: 10.1111/jhn.13054. Epub 2022 Jul 21.
4
Prevalence of disordered eating in adults with gastrointestinal disorders: A systematic review.胃肠道疾病成人患者中饮食失调症的流行率:系统综述。
Neurogastroenterol Motil. 2022 Aug;34(8):e14278. doi: 10.1111/nmo.14278. Epub 2021 Oct 7.
5
When Food Moves From Friend to Foe: Why Avoidant/Restrictive Food Intake Matters in Irritable Bowel Syndrome.当食物从“朋友”变成“敌人”:为何回避/限制型食物摄入在肠易激综合征中至关重要。
Clin Gastroenterol Hepatol. 2022 Jun;20(6):1223-1225. doi: 10.1016/j.cgh.2021.09.017. Epub 2021 Sep 20.
6
Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease.避免限制型食物摄入障碍在炎症性肠病患者中普遍存在。
Clin Gastroenterol Hepatol. 2022 Jun;20(6):1282-1289.e1. doi: 10.1016/j.cgh.2021.08.009. Epub 2021 Aug 11.
7
When Is Patient Behavior Indicative of Avoidant Restrictive Food Intake Disorder (ARFID) Vs Reasonable Response to Digestive Disease?患者的行为何时表明是回避性限制型进食障碍(ARFID),何时表明是对消化疾病的合理反应?
Clin Gastroenterol Hepatol. 2022 Jun;20(6):1241-1250. doi: 10.1016/j.cgh.2021.07.045. Epub 2021 Aug 5.
8
Validation of the nine item ARFID screen (NIAS) subscales for distinguishing ARFID presentations and screening for ARFID.验证九项进食障碍筛查量表(NIAS)分量表区分进食障碍表现和筛查进食障碍的能力。
Int J Eat Disord. 2021 Oct;54(10):1782-1792. doi: 10.1002/eat.23520. Epub 2021 Apr 22.
9
Eating Disorder Examination - Questionnaire short forms: A comparison.进食障碍检查 - 问卷短表:比较。
Int J Eat Disord. 2020 Jun;53(6):937-944. doi: 10.1002/eat.23275. Epub 2020 Apr 13.
10
Food avoidance in outpatients with Inflammatory Bowel Disease - Who, what and why.炎症性肠病门诊患者的食物回避——何人、何物及为何。
Clin Nutr ESPEN. 2019 Jun;31:10-16. doi: 10.1016/j.clnesp.2019.03.018. Epub 2019 Apr 9.

溃疡性结肠炎缓解期时,回避/限制型食物摄入障碍症状不如其他饮食障碍症状常见。

Avoidant/Restrictive Food Intake Disorder Symptoms Are Not as Frequent as Other Eating Disorder Symptoms When Ulcerative Colitis Is in Remission.

机构信息

Harvard Medical School, Boston, MA, USA.

Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.

出版信息

J Crohns Colitis. 2024 Sep 3;18(9):1510-1513. doi: 10.1093/ecco-jcc/jjae052.

DOI:10.1093/ecco-jcc/jjae052
PMID:38635299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11369070/
Abstract

BACKGROUND AND AIM

Recent studies have shown that up to 53% of patients with inflammatory bowel disease [IBD] screen positive for avoidant/restrictive food intake disorder [ARFID]. There is however concern that ARFID screening rates are over-inflated in patients with active disease. We aimed to evaluate the frequency and characteristics of ARFID symptoms using the Nine Item ARFID Screen [NIAS], and to use another eating disorder measure, the Eating Disorder Examination-Questionnaire 8 [EDE-Q8], to rule-out/characterise other eating disorder cognitive and behavioural symptoms.

METHODS

Participants included adults with UC who are enrolled in an ongoing cohort study with quiescent UC (Simple Clinical Colitis Activity Index [SCCAI] ≤2 or faecal calprotectin <150 µg/g with corticosteroid-free clinical remission for ≥3 months) at baseline. We used self-reported data on demographics, gastrointestinal medications, medical comorbidities, NIAS scores, and EDE-Q-8 scores.

RESULTS

We included 101 participants who completed the NIAS at their baseline cohort assessment [age 49.9 ± 16.5 years; 55% female]. Eleven participants [11%] screened positively for ARFID on at least one NIAS subscale [n = 8 male]. Up to 30 participants [30%] screened positive for other eating disorder symptoms [EDE-Q-8 Global ≥2.3]. Overall score distributions on the EDE-Q-8 showed that participants scored highest on the Weight Concern and Shape Concern subscales.

CONCLUSIONS

Among adults with UC in remission, we found a low rate of ARFID symptoms by the NIAS but a high rate of positive screens for other eating disorder symptoms.

摘要

背景与目的

最近的研究表明,高达 53%的炎症性肠病[IBD]患者筛查出回避/限制型食物摄入障碍[ARFID]。然而,人们担心在活动期疾病患者中,ARFID 筛查率过高。我们旨在使用九项 ARFID 筛查量表[NIAS]评估 ARFID 症状的频率和特征,并使用另一种饮食障碍测量工具,即饮食障碍检查问卷 8 项[EDE-Q8],排除/确定其他饮食障碍认知和行为症状。

方法

参与者包括正在参加一项正在进行的队列研究的 UC 成人患者,这些患者在基线时患有缓解期 UC(简单临床结肠炎活动指数[SCCAI]≤2 或皮质类固醇治疗下粪便钙卫蛋白<150 µg/g 且临床缓解持续时间≥3 个月)。我们使用自我报告的数据,包括人口统计学、胃肠道药物、合并症、NIAS 评分和 EDE-Q-8 评分。

结果

我们纳入了 101 名在基线队列评估时完成了 NIAS 的参与者[年龄 49.9±16.5 岁;55%为女性]。11 名参与者[11%]在至少一个 NIAS 亚量表上筛查出 ARFID 阳性[n=8 名男性]。多达 30 名参与者[30%]筛查出其他饮食障碍症状[EDE-Q-8 总分≥2.3]。EDE-Q-8 的总分分布表明,参与者在体重关注和体型关注子量表上得分最高。

结论

在缓解期的 UC 成人中,我们通过 NIAS 发现 ARFID 症状的发生率较低,但其他饮食障碍症状的阳性筛查率较高。